Patents by Inventor Stephen Flack

Stephen Flack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biphenyl-Derivatives as p38 Kinase Inhibitors
    Publication number: 20070142476
    Abstract: Compounds of formula (I): or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
    Type: Application
    Filed: January 31, 2007
    Publication date: June 21, 2007
    Inventors: Richard Angell, Nicola Aston, Paul Bamborough, Mark Bamford, George Cockerill, Stephen Flack, Dramane Laine, Ann Walker
  • Biphenylcarboxylic Amide Derivatives as p38 Kinase Inhibitors
    Publication number: 20070105860
    Abstract: Compounds of formula (I): or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
    Type: Application
    Filed: November 3, 2006
    Publication date: May 10, 2007
    Inventors: Richard Angell, Nicola Aston, Paul Bamborough, Mark Bamford, George Cockerill, Stephen Flack, Dramane Laine, Ann Walker
  • Fused pyrazole derivatives being protein kinase inhibitors
    Patent number: 7166597
    Abstract: Compounds of Formula (I): salts or solvates or physiologically functional derivatives thereof, wherein Z is CH or N, and R1, R2, and R4 are various substituent groups, are protein kinase inhibitors
    Type: Grant
    Filed: August 22, 2001
    Date of Patent: January 23, 2007
    Assignee: Glaxo Group Limited
    Inventors: Michael John Alberti, Ian Robert Baldwin, Mui Cheung, Stuart Cockerill, Stephen Flack, Philip Anthony Harris, David Kendall Jung, Gregory Peckham, Michael Robert Peel, Jennifer Gabriel Badiang, Kirk Stevens, James Marvin Veal
  • Biphenylcarboxylic amide derivatives as p38-kinase inhibitors
    Publication number: 20050020540
    Abstract: Compounds of formula (I): or pharmaceutically acceptable sats or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
    Type: Application
    Filed: October 16, 2002
    Publication date: January 27, 2005
    Inventors: Richard Angell, Nicola Aston, Paul Bamborough, Mark Bamford, George Cockerill, Stephen Flack, Dramane Laine, Ann Walker